9 Meters Biopharma, Inc. (NMTRQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Mar 25, 2026, 4:00 PM EST
9 Meters Biopharma Market Cap
9 Meters Biopharma has a market cap or net worth of $145 as of March 26, 2026. Its market cap has increased by 935.71% in one year.
Market Cap
145.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 2, 2018, 9 Meters Biopharma's market cap has decreased from 125.90M to 145.00, a decrease of -100.00%. That is a compound annual growth rate of -81.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 145.00 | 935.71% |
| Dec 31, 2025 | 14.00 | - |
| Dec 31, 2024 | 14.00 | - |
| Dec 29, 2023 | 14.00 | -100.00% |
| Dec 30, 2022 | 16.32M | -93.48% |
| Dec 31, 2021 | 250.22M | 43.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobac Pharmaceuticals | 250.00 |
| Kiromic BioPharma | 157.00 |
| Regenicin | 153.00 |
| Poniard Pharmaceuticals | 150.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |
| RVL Pharmaceuticals | 111.00 |